Prospective validation of the T cell engager (TCE) score in patients treated with bispecific CD3 TCE antibodies in phase I clinical trials

被引：0
|
作者：
Herbel, N. [1 ]
Ouali, K. [1 ]
Danlos, F-X. [1 ]
Massard, C. P. [1 ]
Goldschmidt, V. [1 ]
Michot, J-M. [1 ]
Laparra, A. [2 ]
Bernard-Tessier, A. [3 ]
Gazzah, A. [1 ]
Bahleda, R. [1 ]
Hollebecque, A. [1 ]
Henon, C. [1 ]
Postel-Vinay, S. [1 ]
Loriot, Y. [1 ]
Ribrag, V. [1 ]
Marabelle, A. [1 ]
Fizazi, K. [3 ]
Aix, S. Ponce [1 ]
Champiat, S. [1 ]
Baldini, C. [1 ]
机构：
[1] Inst Gustave Roussy, Drug Dev Dept, Villejuif, France
[2] Inst Gustave Roussy, DIOPP, Villejuif, France
[3] Gustave Roussy Canc Campus, Med Oncol Dept, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.723
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
657P
引用
收藏
页码：S519 / S519
页数：1
相关论文
共 50 条
  • [21] A Phase 1 Dose Escalation Study of Igm-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies
    Budde, Elizabeth
    Gopal, Ajay K.
    Kim, Won Seog
    Flinn, Ian W.
    Cheah, Chan Yoon Y.
    Nastoupil, Loretta
    Matasar, Matthew J.
    Diefenbach, Catherine S.
    Gregory, Gareth P.
    Qazi, Ibrahim
    Pang, Ching-Fai
    Leabman, Maya
    Hernandez, Genevive
    Sison, Iris
    Keyt, Bruce A.
    Chen, Daniel
    Armand, Philippe
    BLOOD, 2021, 138
  • [22] A CD38/CD28xCD3 Trispecific T-Cell Engager (TCE) As a Potentially Active Agent in Multiple Myeloma Patients Relapsed and/or Refractory ( RRMM) to Anti-CD38 Monoclonal Antibodies (mAbs)
    Zabaleta, Aintzane
    Blanco, Laura
    Kim, Peter
    Bisht, Kamlesh
    Wang, Hongfang
    Van de Velde, Helgi J.
    Lasa, Marta
    Tamariz-Amador, Luis-Esteban
    Otero, Paula Rodriguez
    San Miguel, Jesus
    Paiva, Bruno
    Martin-Sanchez, Esperanza
    BLOOD, 2023, 142
  • [23] Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma
    Fayon, Maxime
    Martinez-Cingolani, Carolina
    Abecassis, Audrey
    Roders, Nathalie
    Nelson, Elisabeth
    Choisy, Caroline
    Talbot, Alexis
    Bensussan, Armand
    Fermand, Jean-Paul
    Arnulf, Bertrand
    Bories, Jean-Christophe
    HAEMATOLOGICA, 2021, 106 (04) : 1193 - 1197
  • [24] A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
    Hipp, S.
    Tai, Y-T
    Blanset, D.
    Deegen, P.
    Wahl, J.
    Thomas, O.
    Rattel, B.
    Adam, P. J.
    Anderson, K. C.
    Friedrich, M.
    LEUKEMIA, 2017, 31 (08) : 1743 - 1751
  • [25] A ROR1 SPECIFIC CD3 BISPECIFIC T-CELL ENGAGER ENGINEERED FOR SOLID TUMORS WITH AN EXPANDED THERAPEUTIC WINDOW
    Rabinovich, Brian
    Zhou, Xueyuan
    Takimoto, Jeffrey
    Song, Paul
    Alici, Evren
    Khanna, Nikhita
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1110 - A1110
  • [26] A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
    S Hipp
    Y-T Tai
    D Blanset
    P Deegen
    J Wahl
    O Thomas
    B Rattel
    P J Adam
    K C Anderson
    M Friedrich
    Leukemia, 2017, 31 : 1743 - 1751
  • [27] Combination of a Novel Fusion Protein CD3εζ28 and Bispecific T Cell Engager Enhances the Persistance and Anti-Cancer Effects of T Cells
    Yu, Feng
    Gao, Yang
    Wu, Yan
    Dai, Anran
    Wang, Xiaoyan
    Zhang, Xiangzhi
    Liu, Guodong
    Xu, Qinggang
    Chen, Dongfeng
    CANCERS, 2022, 14 (19)
  • [28] Development of GD2 and CD3 Targeted Bispecific T-Cell Engaging Antibodies for Neuroblastoma
    Patel, A.
    Thevanesan, C.
    Anderson, J.
    Pule, M.
    Straathof, K.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S136 - S137
  • [29] A Preclinical Population Pharmacokinetic Model for Anti-CD20/CD3 T-Cell-Dependent Bispecific Antibodies
    Ferl, Gregory Z.
    Reyes, Arthur
    Sun, Liping L.
    Cheu, Melissa
    Oldendorp, Amy
    Ramanujan, Saroja
    Stefanich, Eric G.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (03): : 296 - 304
  • [30] UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma
    Caracciolo, Daniele
    Polera, Nicoletta
    Belmonte, Beatrice
    Conforti, Francesco
    Signorelli, Stefania
    Gulino, Alessandro
    Staropoli, Nicoletta
    Tuccillo, Franca Maria
    Bonelli, Patrizia
    Juli, Giada
    Grillone, Katia
    Ascrizzi, Serena
    Cirillo, Maria
    Migale, Leonardo
    Ballerini, Andrea
    Pelizon, Cristina
    Di Martino, Maria Teresa
    Tagliaferri, Pierosandro
    Riillo, Caterina
    Tassone, Pierfrancesco
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (02) : 555 - 560
12345